Genentech, HHS Form Drug Development Partnership
The Department of Health and Human Services has partnered with Genentech to develop medicines that can help address national health security requirements under an “other transaction” agreement. HHS’ Biomedical Advanced Research and Development Authority and the biotechnology firm agreed to share costs of developing a drug portfolio for potential commercialization in compliance with the Pandemic and All […] More